12 In another study, from Slovenia, patients with EGFR mutation–positive disease had a nonsignificant trend toward higher risk of brain metastases at diagnosis. 13 No differences in the distribution of type of EGFR mutation (exon 19 v 21) on the basis of the presence or absence of brain metastases were identified in the current study.
← all excerpts
Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non-Small-Cell Lung Cancer.
1
—
—